Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Announcing CHI's Clinical Trial Auditing Conference, April 24-25, 2017, Boston, MACovering best practices and case studies for developing risk-based auditing practices, establishing CAPA plans, and creating effective audit teams.
Agenda at-a-Glance: RISK-BASED AUDITING Risk-Based Approach across Auditing Types Lydia Milne, Associate Director, Clinical QA, Astellas Assessing Sites' Electronic Health Records for Clinical Research Readiness Linda Maziarz, Director, Clinical Development QA, America's Region, CDQA, GlaxoSmithKline Evolution of an Internal Audit Program Johanna L. Stamates, RN, MA, CCRC, CHRC, Executive Director, RCQA (Research Compliance and Quality Assurance), University of Miami PANEL DISCUSSION: Developing a Risk-Based Auditing Plan for Modern Clinical Trials Moderator: Beverly Brown, Associate Director, Global R&D Quality, Allergan Panelists: Ana Sharma, Global Head, Strategy and Operations, Clinical Development Quality, Novartis Linda Maziarz, Director, Clinical Development Quality Assurance, America's, GSK Lydia Milne, Associate Director, Clinical QA, Astellas SETTING THE STAGE FOR A SUCCESSFUL AUDIT Setting the Stage for a Successful Audit: Building Effective Partnerships with Internal/External Stakeholders Kira Drummond, Sr. Director, R&D Quality Audits and Inspections. Alexion Pharmaceuticals Inc. AUDITING FOR VENDOR QUALIFICATION AND PERFORMANCE Vendor Qualification Approaches Bill Hansen, Outsourcing Compliance and Quality Management, Quality Medicine, Boehringer Ingelheim Pharmaceuticals, Inc. We Hold This Truth to Be Self-Evident: Robyn Lori, Director, GCP Vendor Management, Vertex Pharmaceuticals HEALTH AUTHORITY INSPECTIONS Actionable Insight from Health Authority Inspections Janis Little, Vice President, Global Regulatory Quality, Allergan Lessons Learned from mHealth Canada Health Authority Inspection Derek Hall, Associate Director, Quality Assurance GCP, Incyte ICH E6 R2: EFFECTS ON AUDITING ICH E6 (GCP) Addendum – Impact on Use of Audits? Andy Lawton, Director and Consultant, Risk Based Approach Ltd PLENARY KEYNOTE SESSION: Re-Imagining the Clinical Trial Process: Overcoming Challenges to Innovation Gillian Hodkinson, Vice President, Development Operations, Development, AbbVie Nina Spiller, Vice President, Clinical Management, Otsuka Murray Abramson, M.D., Vice President, Global Clinical Operations, Biogen Spyros Papapetropoulos, Vice President & Global Head, Clinical Development, Movement Disorders & Neurodegenerative Diseases, Teva Keynote Luncheon Presentation: Kyle Given, Vice President, Professional Services, Medidata Solutions Sponsored by: Medidata Solutions Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com. For details on sponsorship, exhibit and lead generation packages, contact Ilana Quigley, Tel: 781-972-5457, iquigley@healthtech.com. For more information and to register, visit http://www.clinicaltrialsummit.com/ About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation Bio-IT World Clinical Informatics News and Diagnostics World. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|